Identification of influenza A nucleoprotein as an antiviral target

被引：219

作者：

Kao, Richard Y. ^{[1
,3
]}

Yang, Dan ^{[4
]}

Lau, Lai-Shan ^{[1
]}

Tsui, Wayne H. W. ^{[1
]}

Hu, Lihong ^{[4
]}

Dai, Jun ^{[1
,2
]}

Chan, Mei-Po ^{[1
]}

Chan, Che-Man ^{[1
]}

Wang, Pui ^{[1
]}

Zheng, Bo-Jian ^{[1
,3
]}

Sun, Jian ^{[4
]}

Huang, Jian-Dong ^{[5
]}

Madar, Jason

Chen, Guanhua ^{[4
]}

Chen, Honglin ^{[1
,3
]}

Guan, Yi ^{[1
,3
]}

Yuen, Kwok-Yung ^{[1
,3
]}

机构：

[1] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China

[2] Univ Hong Kong, Res Ctr Infect & Immunol, Hong Kong, Hong Kong, Peoples R China

[3] Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China

[4] Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China

[5] Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China

来源：

NATURE BIOTECHNOLOGY | 2010年 / 28卷 / 06期

关键词：

OSELTAMIVIR-RESISTANT INFLUENZA; SMALL-MOLECULE INHIBITORS; VIRUS NUCLEOPROTEIN; NUCLEAR-LOCALIZATION; RIBONUCLEOPROTEIN COMPLEXES; VIRAL NUCLEOPROTEIN; CHEMICAL GENETICS; RNA-BINDING; REPLICATION; INFECTIONS;

D O I：

10.1038/nbt.1638

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Influenza A remains a significant public health challenge because of the emergence of antigenically shifted or highly virulent strains(1-5). Antiviral resistance to available drugs such as adamantanes or neuraminidase inhibitors has appeared rapidly(6-9), creating a need for new antiviral targets and new drugs for influenza virus infections. Using forward chemical genetics, we have identified influenza A nucleoprotein (NP) as a druggable target and found a small-molecule compound, nucleozin, that triggers the aggregation of NP and inhibits its nuclear accumulation. Nucleozin impeded influenza A virus replication in vitro with a nanomolar median effective concentration (EC(50)) and protected mice challenged with lethal doses of avian influenza A H5N1. Our results demonstrate that viral NP is a valid target for the development of small-molecule therapies.

引用

页码：600 / U88

页数：8

共 23 条

[1] Nuclear traffic of influenza virus proteins and ribonucleoprotein complexes
Boulo, Sebastien
Akarsu, Hatice
Ruigrok, Rob W. H.
Baudin, Florence
[J]. VIRUS RESEARCH, 2007, 124 (1-2) : 12 - 21
[2] IDENTIFICATION OF THE SEQUENCE RESPONSIBLE FOR THE NUCLEAR ACCUMULATION OF THE INFLUENZA-VIRUS NUCLEOPROTEIN IN XENOPUS OOCYTES
DAVEY, J
DIMMOCK, NJ
COLMAN, A
[J]. CELL, 1985, 40 (03) : 667 - 675
[3] Infections With Oseltamivir-Resistant Influenza A(H1N1) Virus in the United States
Dharan, Nila J.
Gubareva, Larisa V.
Meyer, John J.
Okomo-Adhiambo, Margaret
McClinton, Reginald C.
Marshall, Steven A.
George, Kirsten St.
Epperson, Scott
Brammer, Lynnette
Klimov, Alexander I.
Bresee, Joseph S.
Fry, Alicia M.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (10): : 1034 - 1041
[4] Modulation of nuclear localization of the influenza virus nucleoprotein through interaction with actin filaments
Digard, P
Elton, D
Bishop, K
Medcalf, E
Weeds, A
Pope, B
[J]. JOURNAL OF VIROLOGY, 1999, 73 (03) : 2222 - 2231
[5] Identification of amino acid residues of influenza virus nucleoprotein essential for RNA binding
Elton, D
Medcalf, L
Bishop, K
Harrison, D
Digard, P
[J]. JOURNAL OF VIROLOGY, 1999, 73 (09) : 7357 - 7367
[6] A DNA transfection system for generation of influenza A virus from eight plasmids
Hoffmann, E
Neumann, G
Kawaoka, Y
Hobom, G
Webster, RG
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (11) : 6108 - 6113
[7] Characterization of SARS-CoV main protease and identification of biologically active small molecule inhibitors using a continuous fluorescence-based assay
Kao, RY
To, APC
Ng, LWY
Tsui, WHW
Lee, TSW
Tsoi, HW
Yuen, KY
[J]. FEBS LETTERS, 2004, 576 (03) : 325 - 330
[8] Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics
Kao, RY
Tsui, WHW
Lee, TSW
Tanner, JA
Watt, RM
Huang, JD
Hu, LH
Chen, GH
Chen, ZW
Zhang, LQ
He, T
Chan, KH
Tse, H
To, APC
Ng, LWY
Wong, BCW
Tsoi, HW
Yang, D
Ho, DD
Yuen, KY
[J]. CHEMISTRY & BIOLOGY, 2004, 11 (09): : 1293 - 1299
[9] The potential impact of neuraminidase inhibitor resistant influenza
Lackenby, Angie
Thompson, Catherine I.
Democratis, Jane
[J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2008, 21 (06) : 626 - 638
[10] Pandemic Influenza: An Inconvenient Mutation
Layne, Scott P.
Monto, Arnold S.
Taubenberger, Jeffery K.
[J]. SCIENCE, 2009, 323 (5921) : 1560 - 1561

← 1 2 3 →